Additional file 1 of Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)
Publication Date
January 13, 2023
Creators
Related resources
Resource languages
English
Publisher
Figshare
Date Issued
2021
Except where otherwise noted, this item's license is described as